학술논문
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
Document Type
Article
Author
Source
In Annals of Oncology September 2020 31(9):1178-1185
Subject
Language
ISSN
0923-7534